Canada markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.35-0.49 (-8.39%)
At close: 04:00PM EDT
5.50 +0.15 (+2.80%)
After hours: 05:08PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
9,936
9,936
14,880
23,488
15,093
Operating Expenses
Research Development
108,153
108,153
111,944
99,872
76,065
Selling General and Administrative
28,282
28,282
29,299
23,036
21,325
Total Operating Expenses
136,435
136,435
141,243
122,908
97,390
Operating Income or Loss
-126,499
-126,499
-126,363
-99,420
-82,297
Interest Expense
5,127
5,127
4,134
3,907
1,792
Total Other Income/Expenses Net
-39,764
-39,764
33,711
16,682
-375
Income Before Tax
-164,574
-164,574
-94,654
-86,558
-84,038
Income from Continuing Operations
-164,574
-164,574
-94,654
-86,558
-84,038
Net Income
-164,574
-164,574
-94,654
-86,558
-84,038
Net Income available to common shareholders
-164,574
-164,574
-94,654
-86,558
-84,038
Basic EPS
0.85
-5.81
-7.49
-13.84
-18.20
Diluted EPS
0.85
-5.81
-7.49
-13.84
-18.20
Basic Average Shares
27,917
28,326
12,632
6,253
4,605
Diluted Average Shares
27,917
28,326
12,632
6,253
4,605